AUNLIFSA

Serial Number 98087536
688

Registration Progress

Application Filed
Jul 17, 2023
Under Examination
Feb 25, 2025
Approved for Publication
Dec 31, 2024
Published for Opposition
Dec 31, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Aug 25, 2025 40 days

Trademark Image

AUNLIFSA

Basic Information

Serial Number
98087536
Filing Date
July 17, 2023
Published for Opposition
December 31, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Feb 25, 2025
Application
Pending
Classes
005

Rights Holder

Johnson & Johnson

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

Johnson & Johnson

Original Applicant
03
New Brunswick, NJ

Johnson & Johnson

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Cheryl L. Foytlin

USPTO Deadlines

Next Deadline
40 days remaining
NOA E-Mailed - SOU Required
Due Date
August 25, 2025
Extension Available
Until February 25, 2026

Application History

16 events
Date Code Type Description Documents
Feb 25, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 10, 2025 CHPB I POST PUBLICATION AMENDMENT - ENTERED Loading...
Feb 10, 2025 APET A ASSIGNED TO PETITION STAFF Loading...
Jan 7, 2025 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Dec 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 31, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 3, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 26, 2024 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
May 1, 2024 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Oct 29, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Oct 29, 2023 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Oct 29, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 28, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 15, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of auto-immune and inflammatory diseases, central nervous system diseases, dermatologic diseases, ophthalmic diseases, non-malignant hematological diseases, maternal fetal disorders

Classification

International Classes
005